Search results

Order by most recent / most popular / relevance

Results: 1-10 of 219

House bill would impose litigation costs on losing non-practicing entities

Shook Hardy & Bacon LLP
-
USA
-
March 7 2013

U.S. Reps. Peter DeFazio (D-Ore.) and Jason Chaffetz (R-Utah) have introduced legislation (H.R. 845) that would create a "loser pays" system in

Biotech trade group seeks USDA involvement in gene patents lawsuit

Shook Hardy & Bacon LLP
-
USA
-
October 21 2010

The Biotechnology Industry Organization (BIO) has asked U.S. Department of Agriculture (USDA) Secretary Tom Vilsack to urge the Department of Justice, which is considering the federal government's position in litigation about patent protection for isolated DNA sequences, to "strongly defend the patentability of such basic biotech inventions."

Pharma merger activity attributed to “patent cliff”

Shook Hardy & Bacon LLP
-
USA
-
November 18 2010

Noting that many of the pharmaceutical industry's best-selling products will soon lose their patent protection, industry analysts have reportedly suggested that the potential loss of nearly one-third of industry revenues in the near term could account for recent merger activity among the world's largest pharmaceutical companies

Administration budget-cut plan includes reducing data exclusivity for biologic drugs

Shook Hardy & Bacon LLP
-
USA
-
February 24 2011

Among other provisions included in President Barack Obama’s (D) $3.7 trillion budget proposal is a plan to give biotech drugs seven years of market exclusivity rather than the 12 years already in effect

DOJ seeks earliest calendaring before Federal Circuit in Myriad Genetics

Shook Hardy & Bacon LLP
-
USA
-
February 24 2011

Acting Solicitor General Neal Katyal has requested an April 4, 2011, oral argument date in a case before the Federal Circuit Court of Appeals asking whether and to what extent genetic discoveries may be patented

WIPO announces increase in filings under international patent treaty

Shook Hardy & Bacon LLP
-
Global
-
February 24 2011

The World Intellectual Property Organization (WIPO) has released data on international patent filings under the Patent Cooperation Treaty showing a nearly 5 percent increase from 2009 to 2010

USPTO plan to fast-track humanitarian patent re-examination unsound?

Shook Hardy & Bacon LLP
-
USA
-
December 16 2010

In response to a U.S. Patent and Trademark Office (USPTO) proposal to expedite the re-examination of patents for technologies addressing humanitarian needs, three intellectual property (IP) organizations have apparently filed comments in opposition

USPTO seeks comments on rules for ex parte patent appeals

Shook Hardy & Bacon LLP
-
USA
-
December 16 2010

The U.S. Patent and Trademark Office (USPTO) has issued a notice of proposed rulemaking that seeks public comments on proposed new revisions to current procedures governing practice before the Board of Patent Appeals and Interferences

Stakeholders provide input on FDA review standards for biosimilars

Shook Hardy & Bacon LLP
-
USA
-
November 18 2010

The Food and Drug Administration (FDA) recently conducted a two-day hearing to begin the process of determining how it will go about creating review standards for the generic copies (biosimilars) of prescription drugs developed from biological materials (biologics

Federal Circuit finds no limitation on new evidence in civil patent actions filed in district court

Shook Hardy & Bacon LLP
-
USA
-
November 18 2010

A divided en banc Federal Circuit Court of Appeals has determined that patent applicants who are dissatisfied with a Board of Patent Appeals (Board) determination and decide to pursue their claims in federal court under 35 U.S.C. 145, face no limitations on the right to introduce new evidence other than those pertaining to all civil actions under federal evidentiary and procedural rules

next >

Search results

House bill would impose litigation costs on losing non-practicing entities

Biotech trade group seeks USDA involvement in gene patents lawsuit

Pharma merger activity attributed to “patent cliff”

Administration budget-cut plan includes reducing data exclusivity for biologic drugs

DOJ seeks earliest calendaring before Federal Circuit in Myriad Genetics

WIPO announces increase in filings under international patent treaty

USPTO plan to fast-track humanitarian patent re-examination unsound?

USPTO seeks comments on rules for ex parte patent appeals

Stakeholders provide input on FDA review standards for biosimilars

Federal Circuit finds no limitation on new evidence in civil patent actions filed in district court

Current Search

Suggested Facets

Author

Jurisdiction

Workarea